| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.045 | 0.3 |